Abstract: A composition for the topical treatment of dermal irritation and pain symptoms of neurodermatitis comprising a topical pharmaceutical formulation which contains a therapeutically appropriate dose of a sodium channel blocker selected from the group of ester- or amide-type local anesthetics, wherein the sodium channel blocker is released directly on or in the skin underneath the applied pharmaceutical formulation.

Abstract: The invention relates to a method and composition for synergistic topical therapy of the symptoms of neuromuscular pains. In this method, for intact skin or open skin, there is used a suitable topical pharmaceutical formulation, which is loaded in a suitable dose relationship with a sodium channel blocker from the class of local anesthetics of the ester or amide type and a substance from the class of non-steroidal anti-inflammatory drugs, and which releases these substances selectively onto or under the skin region. By the simultaneous inhibition of the initial inflammatory pain factors at the cellular level and also of the transmission of neuronal pain impulses in reaction thereto, this therapy achieves pharmacologically more effective alleviation of neuromuscular pain.

Abstract: A dermal diagnostic system including an active transponder for an improved mobile and non-invasive detection, transmission, and processing of medically relevant biological base data. The active transponder works in conjunction with at least one sensor arranged in or at an adhesive flexible carrier such that the sensor is provided in adequate measuring contact with the skin surface or subjacent layers and transmit their data to the transponder for external transmission. The dermal system is moreover adapted to be technically connected directly with secondary communication networks. Such a system offers improved medical-diagnostic possibilities.

Abstract: The invention pertains to patch-like chip systems for the thermodynamic control of topical dermal and transdermal systems, especially for improving the efficiency and safety of dermal and transdermal therapies and diagnoses. From an information technological standpoint, the systems represent complex technical devices that, in comparison to conventional passive systems, represent controlled and intelligent systems as a result of programmable and also individual control. Their incorporation into passive dermal or transdermal therapeutic systems requires no technical incursions into the existing structure of such systems. The patch-like chip systems also open up new usage possibilities in the sector of non-invasive and micro-invasive dermal and transdermal diagnosis.